These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 23354111

  • 1. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
    Crandall DG, Revella J, Patterson J, Huish E, Chang M, McLemore R.
    Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1137-45. PubMed ID: 23354111
    [Abstract] [Full Text] [Related]

  • 2. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG, Revella J, Patterson J, Huish E, Chang M, McLemore R.
    Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1128-36. PubMed ID: 23370679
    [Abstract] [Full Text] [Related]

  • 3. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K, Nandyala SV, Marquez-Lara A, Cha TD, Khan SN, Fineberg SJ, Pelton MA.
    Spine J; 2013 Sep 01; 13(9):1118-25. PubMed ID: 24029138
    [Abstract] [Full Text] [Related]

  • 4. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR, Pearce KR, McAnany SJ, Peters CM, Gupta MC, Zebala LP.
    Spine J; 2018 Mar 01; 18(3):439-446. PubMed ID: 28822825
    [Abstract] [Full Text] [Related]

  • 5. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
    Rahman RK, Buchowski JM, Stephens B, Dorward IG, Koester LA, Bridwell KH.
    Spine (Phila Pa 1976); 2013 Dec 15; 38(26):2264-71. PubMed ID: 24108280
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.
    Hoffmann MF, Jones CB, Sietsema DL.
    Spine J; 2013 Oct 15; 13(10):1244-52. PubMed ID: 23973099
    [Abstract] [Full Text] [Related]

  • 8. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.
    Chen NF, Smith ZA, Stiner E, Armin S, Sheikh H, Khoo LT.
    J Neurosurg Spine; 2010 Jan 15; 12(1):40-6. PubMed ID: 20043763
    [Abstract] [Full Text] [Related]

  • 9. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
    Burkus JK, Dryer RF, Peloza JH.
    J Neurosurg Spine; 2013 Feb 15; 18(2):112-21. PubMed ID: 23199378
    [Abstract] [Full Text] [Related]

  • 10. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?
    Mannion RJ, Nowitzke AM, Wood MJ.
    Spine J; 2011 Jun 15; 11(6):527-33. PubMed ID: 20739225
    [Abstract] [Full Text] [Related]

  • 11. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
    Villavicencio AT, Burneikiene S.
    Spine J; 2016 Oct 15; 16(10):1208-1213. PubMed ID: 27343729
    [Abstract] [Full Text] [Related]

  • 12. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients.
    Bess S, Line BG, Lafage V, Schwab F, Shaffrey CI, Hart RA, Boachie-Adjei O, Akbarnia BA, Ames CP, Burton DC, Deverin V, Fu KM, Gupta M, Hostin R, Kebaish K, Klineberg E, Mundis G, O'Brien M, Shelokov A, Smith JS, International Spine Study Group ISSG.
    Spine (Phila Pa 1976); 2014 Feb 01; 39(3):233-42. PubMed ID: 24477081
    [Abstract] [Full Text] [Related]

  • 13. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2.
    Villavicencio AT, Burneikiene S, Nelson EL, Bulsara KR, Favors M, Thramann J.
    J Neurosurg Spine; 2005 Dec 01; 3(6):436-43. PubMed ID: 16381205
    [Abstract] [Full Text] [Related]

  • 14. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).
    Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K.
    Spine J; 2008 Dec 01; 8(6):1011-8. PubMed ID: 18037352
    [Abstract] [Full Text] [Related]

  • 15. Transforaminal lumbar interbody fusion versus anterior lumbar interbody fusion as an adjunct to posterior instrumented correction of degenerative lumbar scoliosis: three year clinical and radiographic outcomes.
    Crandall DG, Revella J.
    Spine (Phila Pa 1976); 2009 Sep 15; 34(20):2126-33. PubMed ID: 19752698
    [Abstract] [Full Text] [Related]

  • 16. Long-term durability of minimal invasive posterior transforaminal lumbar interbody fusion: a clinical and radiographic follow-up.
    Rouben D, Casnellie M, Ferguson M.
    J Spinal Disord Tech; 2011 Jul 15; 24(5):288-96. PubMed ID: 20975594
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL, Ogden K, Robertson IK, Broadhurst S, Edis D.
    Spine (Phila Pa 1976); 2014 Jan 15; 39(2):164-71. PubMed ID: 24153173
    [Abstract] [Full Text] [Related]

  • 18. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK, Gornet MF, Glassman SD, Slosar PJ, Rosner MK, Deckey JE, Nowak J, Hatcher BM.
    Spine (Phila Pa 1976); 2011 Dec 01; 36(25):2158-67. PubMed ID: 21325990
    [Abstract] [Full Text] [Related]

  • 19. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
    Comer GC, Smith MW, Hurwitz EL, Mitsunaga KA, Kessler R, Carragee EJ.
    Spine J; 2012 Oct 01; 12(10):881-90. PubMed ID: 23098617
    [Abstract] [Full Text] [Related]

  • 20. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM, Parker RM, Ellis NJ, Blecher CM, Chow FY, Claydon MH.
    J Neurosurg Spine; 2014 Dec 01; 21(6):851-60. PubMed ID: 25279655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.